Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new opportunities to expand access to their medicines through PAPs.

In a significant shift in the global pharmaceutical landscape, a substantial portion of French medicines is now being ...

Simon-Kucher's industry study reveals barriers and success factors for improving global pricing and marketing access ...

The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization ...

Venture Global LNG could finish power generator repairs by the end of February, a federal inspection report said on Wednesday ...